ADXS Investor Alert – Monteverde & Associates PC and Kahn Swick & Foti, LLC Obtain Material Disclosures Regarding the Upcoming Shareholder Vote for Advaxis, Inc. – ADXS
December 14, 2021: The Hon. Vernon S. Broderick entered an Order approving the selection of KSF as Lead Counsel for the putative Class Siegel v. The Boston Beer Company, Inc. et al., Case No. 1:21-cv-7693-VSB (S.D.N.Y.).
December 8, 2021: The Hon. Vernon S. Broderick entered an Order approving the selection of KSF as Lead Counsel for the putative Class Sandoz v. Waterdrop Inc. et al., Case No. 1:21-cv-7683-VSB (S.D.N.Y.).
December 6, 2021: The Hon. Morgan T. Zurn, Vice Chancellor of the Court of Chancery of the State of Delaware, rendered a ruling finding that plaintiffs represented by Kahn Swick & Foti LLC properly sought books and records to investigate wrongdoing in the process leading up to the merger of Parsley Energy, Inc. in pursuit of a post-close breach of fiduciary duty action.
December 2, 2021: The Hon. Cormac J. Carney entered an Order denying, in substantial part, Defendants’ motion to dismiss against Workhorse Group, Inc. and individual defendants Duane Hughes and Steve Schrader.
December 2, 2021: the Hon. Carolyn B. Kuhl entered an Opinion and Order denying in its entirety defendants’ motion to dismiss plaintiffs’ consolidated complaint.
October 15, 2021: The Hon. Ronnie Abrams entered an Order approving the selection of KSF as Lead Counsel for the putative Class in Re CarLotz, Inc. Securities Litigation, Case No. 1:21-cv-05906-RA (S.D.N.Y.)
October 28, 2021: The Hon. Janis Lynn Sammartino grants final approval to the class action settlement in Khoja v. Orexigen Therapeutics, Inc., approving Lead Plaintiff’s $4.8 million recovery for investors.
On August 23, 2021, the Hon. Lorna G. Schofield, United States District Court Judge for the Southern District of New York, entered an Opinion and Order substantially denying defendants’ motion for summary judgment.
August 24, 2021: The Hon. Arthur J. Tarnow entered a final judgment in the securities class action lawsuit Dougherty v. Esperion Therapeutics, Case No. 2:16-cv-10089, approving Lead Plaintiffs’ $18.25 million recovery.